BRUCE ABRAHAM GREENFIELD

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology LOS ANGELES, CA NPI 1043224686

General Payments — all program years on this page

$5,291.45

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 116
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,138.69 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,114.0841
Education $24.611

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $111.705
2019 $181.806
2020 $262.738
2021 $1,998.4110
2022 $771.6414
2023 $826.4831
2024 $1,138.6942

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086953745 Novartis Pharmaceuticals Corporation $22.15 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086953753 Novartis Pharmaceuticals Corporation $16.81 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091145256 ANI Pharmaceuticals, Inc. $19.71 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091159436 ANI Pharmaceuticals, Inc. $15.18 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093896134 Alexion Pharmaceuticals, Inc. $31.61 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093920756 Alexion Pharmaceuticals, Inc. $130.99 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094019691 Alexion Pharmaceuticals, Inc. $39.04 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094036084 Alexion Pharmaceuticals, Inc. $130.91 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104673185 AstraZeneca Pharmaceuticals LP $25.76 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105263310 AstraZeneca Pharmaceuticals LP $21.03 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589104 Amgen Inc. $9.20 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589106 Amgen Inc. $12.74 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589108 Amgen Inc. $7.83 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589110 Amgen Inc. $6.44 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589112 Amgen Inc. $15.61 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589114 Amgen Inc. $4.14 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589116 Amgen Inc. $9.99 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589118 Amgen Inc. $4.55 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589120 Amgen Inc. $10.19 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589122 Amgen Inc. $1.91 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589124 Amgen Inc. $12.37 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589126 Amgen Inc. $8.83 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589128 Amgen Inc. $5.91 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589130 Amgen Inc. $5.32 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589132 Amgen Inc. $9.99 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589134 Amgen Inc. $4.48 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589136 Amgen Inc. $6.81 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111589138 Amgen Inc. $17.76 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112844960 OPKO Pharmaceuticals, LLC $24.41 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117848007 Boehringer Ingelheim Pharmaceuticals, Inc. $21.69 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141507932 CALLIDITAS THERAPEUTICS US INC. $24.85 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145824074 AKEBIA THERAPEUTICS INC $26.47 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145830247 AKEBIA THERAPEUTICS INC $28.01 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832463 AKEBIA THERAPEUTICS INC $24.61 07/23/2024 Education Undisputed 01/23/2026 View at CMS
1146682941 Ardelyx, Inc. $119.51 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146682943 Ardelyx, Inc. $25.76 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146682945 Ardelyx, Inc. $2.11 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146682947 Ardelyx, Inc. $4.17 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152975232 ShockWave Medical, Inc $164.71 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154192041 Fresenius USA Marketing, Inc. $19.09 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154192043 Fresenius USA Marketing, Inc. $22.46 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154192045 Fresenius USA Marketing, Inc. $23.58 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.